Securities News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–2 of 2 articles
Earlier
High impact NewsApr 26, 2026
Atara Biotherapeutics Faces Securities Class Action Lawsuit with May 2026 Deadline for Lead Plaintiff Applications
2 min
Dr. Natalie HughesHigh impact NewsApr 24, 2026
ImmunityBio (IBRX) Faces FDA Warning Letter and Class Action Lawsuit Over Anktiva Claims
Oncology/Immunotherapy · 3 min
Dr. Sarah MitchellExplore intelligence